Genomind Stock
Genomind is a personalized medicine company specializing in neuropsychiatry.
Sign up today and learn more about Genomind Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Genomind Stock
Genomind is a personalized medicine company specializing in neuropsychiatry. It was founded by a psychiatrist, Dr. Ronald Dozoretz, and a neurologist, Dr. Jay Lombard, who share a common goal of wanting the best possible care for patients who suffer from psychiatric illness. It was founded in 2009 and headquartered in Chalfont, Pennsylvania.
Funding History
| April 2014 | $20.9M |
|---|---|
| April 2016 | $17.9M |
| July 2016 | $3.0M |
| February 2017 | $11.0M |
| July 2018 | $500K |
| September 2020 | $20.6M |
Management
Founder
Ronald I. Dozoretz
Director of Behavioral Science
Francis Brennan
Advisor
Stephen Stahl
Advisor
Scott Aaronson
Advisor
Anil Malhotra
Advisor
Allan Levey
Advisor
Rudolph Tanzi
CEO
Cynthia Kilroy
Chairman of the Board of Directors
Ronald I. Dozoretz
Chief Medical Officer
David Krause
Advisor
Murali Doraiswamy
Advisor
Roy Perlis
Chief Information Officer
Jon Levine
Chief Scientific Officer
David Robbins
US Sales Leader
Laura Miles
Press
dealstreetasia - Sep, 15 2021
GeneMind nets $64m and 10 more deal updates from Greater Chinagenomeweb - Jan, 26 2021
Genomind Receives Medicare Coverage for Pharmacogenetics Testinquirer - Jan, 3 2020
Genetic test at Acme pharmacies guides choice of psychiatric medicationsbusinesswire - Dec, 17 2019
Genomind Expands Collaboration to Provide Access to Genetics-Based Mental Health Test to Customers in All Pennsylvania ACME Marketsgenomeweb - Oct, 2 2019
Genomind to Further Integrate Genetic Tests Into DrChrono EHRbusinesswire - Sep, 17 2019
Researchers Present New Data on the Utility of Genomind's Mental Health Pharmacogenomic Testing at Upcoming Scientific Conferencesbusinesswire - May, 15 2019
Genomind Inc. Recruits Group of World-Renowned Experts in Psychiatry and Neurology to Advance Its Commitment to Mental Health Innovationprweb - Jun, 22 2018
Standard Process Partners With Genomind To Offer Mindful DNA – A Breakthrough In Personalized Wellnessprnewswire - Mar, 7 2018
A Breakthrough in Personalized Wellness: Mindful DNA™ Genetic Testingprnewswire - Dec, 21 2017
Radio Program 'In Your Right Mind' Explores Genetic Testing for Personalized Medicine in a New Broadcast on 790 AM KABCprnewswire - Dec, 13 2017
Trio of Awards Cap Ground-Breaking Year for Genomind and Its Unique Platformmarketwired - Mar, 27 2016
'Dr. Phil' Show to Feature Genomind's Genecept Assay™ in Upcoming Program Aimed at Helping a Patient Get Better, Fasterprweb - Jan, 30 2016
Innovations to Air New Episode via Discovery Channel, Airing Saturday, January 30, 2016marketwired - Dec, 26 2015
Genomind's Cutting-Edge Pharmacogenetic Testing to Be Featured on Educational "Innovations" TV Seriesmcall - Nov, 4 2015
Hires and promotions at Lehigh Valley businessesmarketwired - Oct, 7 2015
Personalized Medicine for Mental Health Revolutionizes Care as Advocates Mark Mental Illness Awareness Week and World Mental Health Dayprweb - Sep, 29 2015
Innovations to Showcase Genomind, Inc. in Upcoming Episode, Airing via Discoveryfinsmes - Apr, 9 2014
FinSMEs | Genomind Closes $5M FinancingEquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
